• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Infectious disease rapid diagnostic test AbC-19™
for antibodiesSARS-COV-2blood

infectious disease rapid diagnostic test
infectious disease rapid diagnostic test
infectious disease rapid diagnostic test
Add to favorites
Compare this product
 

Characteristics

Applications
for infectious diseases
Tested parameter
for antibodies
Micro-organism
SARS-COV-2
Sample type
blood
Analysis mode
lateral flow
Other characteristics
digital
Result display time

20 min

Specificity

99.6 %

Sensitivity

98 %

Description

AbC-19™ is a lateral flow test that detects SARS-CoV-2 (COVID-19) neutralising antibodies before creating an antibody certificate via a smartphone app. This flexible, easy solution shows confirmation to individuals who have developed IgG neutralising antibodies following COVID-19 infection or vaccination. Neutralising antibodies are an important factor in the determination of a person’s immunity status. Healthcare professionals, laboratory professionals or trained lay providers can use this reliable and accurate rapid test (Sensitivity: 98.03%, Specificity: 99.56%) before sending an antibody certificate to someone for storing on their smartphone. This COVID-19 antibody certificate service may hold the key to help determine if someone is fit to fly or safe to attend a large event. To learn how our AbC-19™ solution can be part of the strategy to open up your business or community, contact Abingdon Health.

VIDEO

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.